The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19 –a systematic review and meta-analysis
- 26 March 2021
- journal article
- review article
- Published by Elsevier BV in Indian Journal of Medical Microbiology
- Vol. 39 (2), 159-170
- https://doi.org/10.1016/j.ijmmb.2021.03.002
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19The New England Journal of Medicine, 2020
- A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID‐19Academic Emergency Medicine, 2020
- In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effectMicrobial Pathogenesis, 2020
- A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease‐19 (COVID‐19)International Journal of Rheumatic Diseases, 2020
- Of chloroquine and COVID-19Antiviral Research, 2020
- Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational studyTravel Medicine and Infectious Disease, 2020
- The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cellsPublished by Cold Spring Harbor Laboratory ,2020
- Assessing risk of bias in studies that evaluate health care interventions: recommendations in the misinformation ageJournal of Clinical Epidemiology, 2018
- Antiviral Treatment Guidelines for Middle East Respiratory SyndromeInfection & Chemotherapy, 2015
- Chloroquine is a potent inhibitor of SARS coronavirus infection and spreadVirology Journal, 2005